<DOC>
	<DOCNO>NCT00225745</DOCNO>
	<brief_summary>The primary outcome measure study plasma ghrelin level .</brief_summary>
	<brief_title>Ghrelin Levels Pancreatic Cancer Patients</brief_title>
	<detailed_description>The primary outcome measure study plasma ghrelin level , two primary comparison : - Patients cachexia versus patient without cachexia - Patients cachexia versus healthy control</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Histological cytological proof pancreatic adenocarcinoma The control include healthy agematched patient without cancer The test arm include patient pancreatic cancer divide two group : without weight loss Patients must recover major infection and/or surgical procedure Patients serious medical illness like congestive heart failure , thyroid disease , liver disease renal failure condition alter nutritional state Patients appetite stimulant receive total parenteral nutrition Patients undergone gastrectomy gastric ulcer Patients receive active chemotherapy No prior malignancy except adequately treat basal cell squamous cell skin cancer , situ cervical cancer patient disease free least five year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Ghrelin</keyword>
</DOC>